Covid-19 breath test startup Breathonix raising US$5m capital

Singapore

BREATHONIX, a Singapore-based startup which has gotten provisional authorisation locally for its Covid-19 breath test, is raising US$5 million in Series A funding to fuel its growth.

"At this stage now, we are growing very fast. We're expanding our team for commercialisation, so we're actively raising more funds," co-founder and chief operating officer Du Fang said during a Monday virtual press conference.